Tempus and Biovica International mutually ended a potential partnership agreement while reviewing US commercial strategy.
2 reports, 1 independent
Updated Sep 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tempus and Biovica International mutually ended a potential partnership agreement while reviewing US commercial strategy.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Patent granted for immuno-oncology technology as Biovica terminated its US strategy agreement with Tempus.1 source
Tempus and Biovica International terminated a potential partnership agreement.1 source
Keep exploring
The entities involved
-
Tempus
biotechnology company based in Chicago, Illinois